Neuropathy in Parkinson disease Prevalence and determinants

Neurology

Volumn 77, Issue 22, 2011, Pages 1947-1950

  Rajabally, Yusuf A ^a   Martey, Jean ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; LEVODOPA;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE DURATION; DRUG EXPOSURE; FEMALE; HUMAN; MALE; NEUROPATHY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; VITAMIN BLOOD LEVEL;

EID: 82955243787     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31823a0ee4     Document Type: Article

References (10)

1. Toth C, Breithaupt K, Ge S, et al. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson's disease. Ann Neurol 2010;67:28-36.
2. Toth C, Brown MS, Furtado S, Suchowersky O, Zochodne D. Neuropathy as a potential complication of levodopa use in Parkinson's disease. Mov Disord 2008;23:1850-1859.
3. Manca D, Cossu G, Murgia D, et al. Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy. Mov Disord 2009;15:2293-2294.
4. Urban PP, Wellach I, Faiss S, et al. Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 2010; 25:1748-1752.
5. Singleton JR, Bixby B, Russell JW, et al. The Utah Early Neuropathy Scale: A sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst 2008;13:218-227.
6. England JD, Gronseth GS, Franklin G, et al. Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review): Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009;72:185-192.
7. Montastruc JL, Danton AC, Durrieu G, et al. Neuropathy as a potential complication of levodopa use in Parkinson's disease: A pharmacological and pharmacovigilance point of view. Mov Disord 2010;25:660-661.
8. Nolano M, Provitera V, Lanzillo B, Santoro L. Neuropathy in idiopathic Parkinson's disease: An iatrogenic problem? Ann Neurol 2010;69:427-429.
9. Gondim FA, de Oliviera GR, Peixoto AA Jr, Horta WG. A case series of peripheral neuropathy in patients with Parkinson's disease. Ann Neurol 2010;68:973-975.
10. Weinberger M, Inzelberg R. "Double crush" in Parkinson's disease. Ann Neurol 2010;68:972-973.